A Phase 1, 2-Way Crossover Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex Donepezil 5 mg Transdermal Delivery System (TDS) in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Jul 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Corium International
- 16 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Oct 2018.
- 16 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Aug 2018.
- 16 Jul 2018 Status changed from recruiting to active, no longer recruiting.